1-4 of 4
Xuelian Hu
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Efficacy and Safety of Glofitamab Combined with Tislelizumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Preliminary Results

De Zhou, Wenjuan Yu, Xin Huang, Juying Wei, Liping Mao, Xingnong Ye, Ehsan Ghoushi, Xiaolong Zheng, Xuelian Hu, Jie Jin, Wanzhuo Xie, Hongyan Tong
Journal: Blood
Blood (2024) 144 (Supplement 1): 6496.
https://doi.org/10.1182/blood-2024-198413
Published: 2024
Journal Articles

Efficacy and safety of CAR19/22 T-cell cocktail therapy in patients with refractory/relapsed B-cell malignancies

Clinical Trials & Observations
Na Wang, Xuelian Hu, Wenyue Cao, Chunrui Li, Yi Xiao, Yang Cao, Chaojiang Gu, Shangkun Zhang, Liting Chen, Jiali Cheng, Gaoxiang Wang, Xiaoxi Zhou, Miao Zheng, Xia Mao, Lijun Jiang, Di Wang, Qiuxiang Wang, Yaoyao Lou, Haodong Cai, Dandan Yan, Yicheng Zhang, Tongcun Zhang, Jianfeng Zhou, Liang Huang
Journal: Blood
Blood (2020) 135 (1): 17–27.
https://doi.org/10.1182/blood.2019000017
Published: 2020
Includes: Supplemental data
Journal Articles

Phosphatase Wip1 controls antigen-independent B-cell development in a p53-dependent manner

Weiwei Yi, Xuelian Hu, Zhiyang Chen, Leiming Liu, Yuan Tian, Hui Chen, Yu-sheng Cong, Fan Yang, Lianfeng Zhang, Karl Lenhard Rudolph, Zhixin Zhang, Yong Zhao, Zhenyu Ju
Journal: Blood
Blood (2015) 126 (5): 620–628.
https://doi.org/10.1182/blood-2015-02-624114
Published: 2015
Includes: Supplemental data
Journal Articles

Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1

Guangwei Liu, Xuelian Hu, Bo Sun, Tao Yang, Jianfeng Shi, Lianfeng Zhang, Yong Zhao
Journal: Blood
Blood (2013) 121 (3): 519–529.
https://doi.org/10.1182/blood-2012-05-432674
Published: 2013
Includes: Supplemental data